These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 23325491)
21. Design, synthesis, and in-vivo pharmacological screening of N,3-(substituted diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamide derivatives. Siddiqui N; Alam P; Ahsan W Arch Pharm (Weinheim); 2009 Mar; 342(3):173-81. PubMed ID: 19194967 [TBL] [Abstract][Full Text] [Related]
22. Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives. Saravanan G; Panneerselvam T; Alagarsamy V; Kunjiappan S; Parasuraman P; Murugan I; Dinesh Kumar P Drug Dev Res; 2018 Sep; 79(6):260-274. PubMed ID: 30244475 [TBL] [Abstract][Full Text] [Related]
23. Search for potential anticonvulsant drugs: part I. Synthesis of 2-phenyl-3-benzimidazolyl/-alkyl (alkyl-aryl)--quinazolin (3H) -4-one. Misra VS; Pandey RN; Dhavan KN Pol J Pharmacol Pharm; 1977; 29(5):543-8. PubMed ID: 593969 [TBL] [Abstract][Full Text] [Related]
24. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents. Kaushik D; Khan SA; Chawla G Eur J Med Chem; 2010 Sep; 45(9):3960-9. PubMed ID: 20573424 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of some 3-substituted-2-[(2,4-dichlorophenoxy)-methyl]quinazolin-4(3H)-one derivatives as potential anticonvulsant agents. Abbas Sel-S; Awadallah FM; Ibrahim NA; Said EG; Kamel G Chem Pharm Bull (Tokyo); 2013; 61(7):679-87. PubMed ID: 23812393 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Abdel-Aziz M; Abuo-Rahma Gel-D; Hassan AA Eur J Med Chem; 2009 Sep; 44(9):3480-7. PubMed ID: 19268406 [TBL] [Abstract][Full Text] [Related]
27. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives. Abuelizz HA; Dib RE; Marzouk M; Anouar EH; A Maklad Y; N Attia H; Al-Salahi R Molecules; 2017 Jun; 22(7):. PubMed ID: 28665338 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides. Kowalczyk P; Sałat K; Höfner GC; Mucha M; Rapacz A; Podkowa A; Filipek B; Wanner KT; Kulig K Eur J Med Chem; 2014 Aug; 83():256-73. PubMed ID: 24973660 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective. Hassan MZ; Khan SA; Amir M Eur J Med Chem; 2012 Dec; 58():206-13. PubMed ID: 23124217 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor. Zayed MF; Ihmaid SK; Ahmed HE; El-Adl K; Asiri AM; Omar AM Molecules; 2017 Jan; 22(2):. PubMed ID: 28125041 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants. Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Ozdemir Z; Kandilci HB; Gümüşel B; Caliş U; Bilgin AA Eur J Med Chem; 2007 Mar; 42(3):373-9. PubMed ID: 17069933 [TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents. Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel 3-(alkylcarbamoyl)-2-aryl-1,2-dihydro-6,7-(methylenedioxy)-3H-quinazolin-4-ones as anticonvulsant agents. Micale N; Postorino G; Grasso S; Zappalà M; Zuccalà G; Ferreri G; De Sarro G Chem Biodivers; 2006 Mar; 3(3):304-11. PubMed ID: 17193267 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticonvulsant activity evaluation of 4-(2-alkoxy-phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-ones in various experimental seizure models in mice. Cao X; Deng XQ; Shu B; Wang SB; Quan ZS Drug Res (Stuttg); 2013 Jun; 63(6):319-25. PubMed ID: 23539424 [TBL] [Abstract][Full Text] [Related]
37. Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice. Jastrzebska-Wiesek M; Librowski T; Czarnecki R; Marona H; Nowak G Pol J Pharmacol; 2003; 55(3):461-5. PubMed ID: 14506327 [TBL] [Abstract][Full Text] [Related]
38. Design of benzothiazole-1,3,4-thiadiazole conjugates: synthesis and anticonvulsant evaluation. Siddiqui N; Ahuja P; Malik S; Arya SK Arch Pharm (Weinheim); 2013 Nov; 346(11):819-31. PubMed ID: 24081512 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies. Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and anticonvulsant evaluation of N-(benzo[d]thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide derivatives: a hybrid pharmacophore approach. Malik S; Bahare RS; Khan SA Eur J Med Chem; 2013 Sep; 67():1-13. PubMed ID: 23831504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]